English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
U.S. House of Representatives
Nicholas Malfitano
| Jun 11, 2024
U.S. House Energy and Commerce on Oversight and Investigations Subcommittee Chair Griffith on 340B Program: 'it is not mandated to disclose where these dollars actually go and how much is made from the program'
Andy Nghiem
| Mar 15, 2022
New $1.5 trillion bill leaves out reimbursement for 'extremely valuable' home telehealth services
Michael McGrady
| Jun 15, 2017
Drug user fee reauthorization may spark innovation
John Breslin
| May 3, 2017
House poised to vote on amended health care bill
John Breslin
| Apr 3, 2017
No move on Republican health care bill for months, expert predicts
John Breslin
| Mar 30, 2017
Low income, older people would have paid higher penalties under House health care bill
John Breslin
| Mar 27, 2017
Postal Service health care proposal could burden seniors, analyst says
John Breslin
| Mar 14, 2017
Supporters of House health care bill emerging, urging GOP unity
Trending
+
Pharmaceuticals
Patient Daily
| Jun 5, 2025
Exon 20 Group questions effectiveness of 340B drug program
+
Pharmaceuticals
Patient Daily
| Jun 9, 2025
Director of Public Affairs of PhRMA: ‘There is also evidence that 340B is harming state and federal budgets’
+
Pharmaceuticals
Patient Daily
| Jun 5, 2025
New study identifies indicators for HER2+ breast cancer therapy response
+
Pharmaceuticals
Patient Daily
| Jun 4, 2025
American Lung Association offers guidance on Saharan dust impact on health